CHA Hospital’s premium medical center, Chaum, announced the development of South Korea’s first cell booster leveraging the power of mitochondria. This innovative treatment aims to combat skin aging at its source.
The center’s new Mito Cell-Booster utilizes both platelets and plasma, capitalizing on their high concentration of mitochondria. By focusing on cellular energy decline, a major contributor to skin aging, the booster enhances the skin’s natural regenerative capabilities.
Mitochondria, the cell’s powerhouse, are responsible for producing adenosine triphosphate (ATP), the primary energy source. As mitochondrial function declines, it manifests as visible signs of aging, including hyperpigmentation, loss of skin elasticity, dryness, rough skin texture, and wrinkles.
To maximize the benefits of mitochondria, Chaum’s approach differs significantly from traditional platelet-rich plasma (PRP) procedures. While standard PRP treatments isolate a small number of platelets from the middle layer after centrifugation, discarding most of the plasma, the Mito Cell-Booster leverages mitochondria derived from both platelets and plasma for a more comprehensive treatment.
Jin Seok-in, a professor at Chaum’s Dermatology and Plastic Surgery Clinic, emphasizes the procedure’s focus on long-term skin health.
“The Mito Cell-Booster is a cell-level treatment designed to foster an environment where the skin can naturally repair and rejuvenate itself,” Professor Jin explained. “By revitalizing cellular energy, it represents a novel approach to cell booster therapy, providing a more profound and enduring improvement in skin health.”
shinjh
